All Posts
FDA Approval of Lirafugratinib
We are pleased to share this announcement with our community from the Acting Director of the FDA Oncology Center of…
2027 Industry Partnership Opportunities
For more information on our industry partnership programs, please visit our CCF Industry Partners webpage at curecca.org/industry-partners Catalog Industry Partnership…
Video: Biomarker Testing Explained
Click on video to play and expand.CCF's Director of Research, Amanda Nottke, PhD, explains what biomarker test results can mean…
Community Champion: Climbing with Keaton Herzer
Words that come to mind when describing Keaton Herzer: resilience, determination, and courage. But even these descriptions don’t begin to…
Kayla’s Story: Hope & Joy Through a Second Cancer Journey
by Nicole Borey, Kayla's Mom Kayla is 21 years old, and unfortunately, cancer has been part of her story for…
Employment Application for Executive Assistant to the Chief Patient Officer
Thank you for your interest in joining the Cholangiocarcinoma Foundation team. Please complete the form below to apply. If you…
Employment Application for Chief Development Officer
Thank you for your interest in joining the Cholangiocarcinoma Foundation team. Please complete the form below to apply. If you…
FDA Approves OncoSil™ Device for Distal Cholangiocarcinoma
A new treatment option is now available for some patients with distal cholangiocarcinoma (dCCA) in the United States. On August…
Simposio Regional de Houston 2026
El Simposio de Colangiocarcinoma de Houston 2026 reunirá en Houston a destacados expertos, investigadores, profesionales de la salud, pacientes y…
Simposio Regional de Los Ángeles 2026
El Simposio de Colangiocarcinoma de Los Ángeles 2026 reunirá en Los Ángeles a destacados expertos, investigadores, profesionales de la salud,…